Immutep (ASX:IMM) company update

Published: Dec. 1, 2020, 4:20 p.m.

03 Dec 2020 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt provides an update on the company, discussing a recent capital raise and results in lung cancer and head and neck cancer.